Search research articles
Contact Us
Filters
Showing results (31-40 of 228) with videos related to
Page
of 23
Sort By:
Nature Reviews. Drug Discovery
|
September 21, 2022
Emerging principles of cytokine pharmacology and therapeutics
Robert A Saxton, Caleb R Glassman, K Christopher Garcia
Prevention Science : the Official Journal of the Society for Prevention Research
|
September 20, 2022
Inconsistencies in Adolescent Self-Reported Sexual Behavior: Experience from Four Randomized Controlled Trials
Jill R Glassman, Elizabeth R Baumler, Karin K Coyle
Ophthalmology
|
November 22, 2017
Reply
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman
JAMA
|
May 23, 2023
Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy-Reply
Jennifer K Sun, Adam R Glassman, Raj K Maturi, et al.
The New England Journal of Medicine
|
July 30, 2015
Targeting the Effect of VEGF in Diabetic Macular Edema
John A Wells, Adam R Glassman, Lee M Jampol
JAMA Ophthalmology
|
March 3, 2022
Spotlight on the DRCR Retina Network's Photobiomodulation for Diabetic Macular Edema Trial
Jennifer K Sun, Adam R Glassman, Lee M Jampol
American Journal of Ophthalmology
|
September 4, 2007
The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials
Abdhish R Bhavsar, Michael S Ip, Adam R Glassman, et al.
The New England Journal of Medicine
|
July 30, 2020
Evaluation and Care of Patients with Diabetic Retinopathy. Reply
Lee M Jampol, Adam R Glassman, Jennifer K Sun
JAMA Ophthalmology
|
November 11, 2021
Managing Center-Involved Diabetic Macular Edema With Good Visual Acuity
Jennifer K Sun, Adam R Glassman, Lee M Jampol
JAMA Ophthalmology
|
June 19, 2015
Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network
Lee M Jampol, Adam R Glassman, Neil M Bressler
Page
of 23
Search research articles
Search
Showing results (31-40 of 228) with videos related to
Sort By:
Page
of 23
Nature Reviews. Drug Discovery
|
September 21, 2022
Emerging principles of cytokine pharmacology and therapeutics
Robert A Saxton, Caleb R Glassman, K Christopher Garcia
Prevention Science : the Official Journal of the Society for Prevention Research
|
September 20, 2022
Inconsistencies in Adolescent Self-Reported Sexual Behavior: Experience from Four Randomized Controlled Trials
Jill R Glassman, Elizabeth R Baumler, Karin K Coyle
Ophthalmology
|
November 22, 2017
Reply
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman
JAMA
|
May 23, 2023
Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy-Reply
Jennifer K Sun, Adam R Glassman, Raj K Maturi, et al.
The New England Journal of Medicine
|
July 30, 2015
Targeting the Effect of VEGF in Diabetic Macular Edema
John A Wells, Adam R Glassman, Lee M Jampol
JAMA Ophthalmology
|
March 3, 2022
Spotlight on the DRCR Retina Network's Photobiomodulation for Diabetic Macular Edema Trial
Jennifer K Sun, Adam R Glassman, Lee M Jampol
American Journal of Ophthalmology
|
September 4, 2007
The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials
Abdhish R Bhavsar, Michael S Ip, Adam R Glassman, et al.
The New England Journal of Medicine
|
July 30, 2020
Evaluation and Care of Patients with Diabetic Retinopathy. Reply
Lee M Jampol, Adam R Glassman, Jennifer K Sun
JAMA Ophthalmology
|
November 11, 2021
Managing Center-Involved Diabetic Macular Edema With Good Visual Acuity
Jennifer K Sun, Adam R Glassman, Lee M Jampol
JAMA Ophthalmology
|
June 19, 2015
Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network
Lee M Jampol, Adam R Glassman, Neil M Bressler
Page
of 23